Login

Interview with Brian Cox, SurgePays CEO, regarding $SURG.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ; 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Interview with Valeria Sandei, CEO Almawave | Valeria Sandei, CEO, Almawave SpAAIW:MIL
00:10:00
On this episode of #TheExchange, Goldman Sachs Asset Management's Alexa Gordon discusses the recently launched Goldman Sachs initiative.|John Waldron is President and Chief Operating Officer of The Goldman Sachs Group
00:10:00
Unveiling the Potential: Exploring Vizsla Silver's Panuco Project with CEO Michael Konnert | Michael A. Konnert - President, CEO of Vizsla Silver Corp.
00:10:00
Biogen CEO on Revolutionizing Drug Development for Rare Diseases with n-Lorem | CHRISTOPHER A. VIEHBACHER, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BIOGEN
00:10:00
Interview Paulina Zelazna | Elie Cohen, CEO, Consort NT SAMLCNT:PAR
00:00:00
Mario Hevesi, M.D., Ph.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
Exploring Diverse Meeting Opportunities and Debt Funds at 121 Mining Investment Conference
00:10:00
Maximizing Capital Gains Deferral: Advanced 1031 Exchange Strategies | KRISTOPHER (KRIS) SCHNELL - President & Founder of Cogent Independent Advisors, Inc.
00:10:00
Culture Rooted in Social Capital Drives Long-Term Success
00:10:00
Exclusive Discussion with Mark Okada on Private Credit Markets and Economic Trends | Charles Kaye, Chief Executive Officer, Warburg Pincus.
00:10:00
ZIDA CEO Tafadzwa Chinamo Addresses Mine Africa Inc Conference in Toronto
00:10:00
invests early growth capital in businesses that demonstrate a direct correlation between high impact and returns|Jyotsna Krishnan,Managing Partner,Elevar Equity

© 2017 - Neuhu+